{{Chembox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 451725338
| ImageFile = Clonixin.png
| IUPACName = 2-(3-chloro-2-methylanilino)pyridine-3-carboxylic acid
| OtherNames = Clonixic acid; CBA 93626<ref name="Clinical">{{cite journal|url=http://onlinelibrary.wiley.com/doi/10.1177/009127007101100508/abstract|title=Clonixin: A Clinical Evaluation of a New Oral Analgesic |accessdate=2015-05-21|doi=10.1177/009127007101100508}}</ref>
|Section1={{Chembox Identifiers
| Abbreviations = 
| CASNo_Ref = {{cascite|correct|??}}
| CASNo = 17737-65-4
| PubChem = 28718
| SMILES = O=C(O)C1=CC=CN=C1NC2=C(C)C(Cl)=CC=C2
| MeSHName = 
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 26711
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1332971
| InChI = 1/C13H11ClN2O2/c1-8-10(14)5-2-6-11(8)16-12-9(13(17)18)4-3-7-15-12/h2-7H,1H3,(H,15,16)(H,17,18)
| InChIKey = CLOMYZFHNHFSIQ-UHFFFAOYAG
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C13H11ClN2O2/c1-8-10(14)5-2-6-11(8)16-12-9(13(17)18)4-3-7-15-12/h2-7H,1H3,(H,15,16)(H,17,18)
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = CLOMYZFHNHFSIQ-UHFFFAOYSA-N
| ChEBI_Ref = {{ebicite|changed|???}}
| ChEBI = 76200
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = 
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D03555
 }}
|Section2={{Chembox Properties
| C=13 | H=11 | Cl=1 | N=2 | O=2
| Appearance = 
| Density = 
| MeltingPt = 
| MeltingPt_notes = 
| BoilingPt = 
| BoilingPt_notes = 
| Solubility = 
| SolubleOther = 
| Solvent = 
 }}
|Section3={{Chembox Pharmacology
| AdminRoutes = [[per os]]
| Bioavail = 
| Metabolism = Glucuronidation via UGT2B7
| HalfLife = 
| ProteinBound =
| Excretion = 
| Legal_status = 
| Legal_US = Not sold in the U.S.
 }}
|Section4={{Chembox Hazards
| RPhrases = 
| SPhrases = 
| LD50 = 
 }}
}}

'''Clonixin''' is a [[nonsteroidal anti-inflammatory drug]] (NSAID). It also has [[analgesic]], [[antipyretic]], and [[Antiplatelet drug|platelet-inhibitory]] actions. It is used primarily in the treatment of chronic arthritic conditions and certain soft tissue disorders associated with pain and inflammation.

==Synthesis==
[[File:Clonixin synthesis.svg|thumb|center|700px|Clonixin synthesis: M. H. Sherlock, N. Sperber, {{Cite patent|BE|679271}}; eidem, {{US patent|3337570}} (1966, 1967 both to [[Schering]]).]]

==[[Clonixeril]]==
The glyceryl ester of clonixin, clonixeril, is also a NSAID. It was prepared by a somewhat roundabout method.
[[File:Clonixeril synthesis.svg|thumb|center|700px|Clonixeril synthesis:<ref>M. H. Sherlock, {{Cite patent|ZA|6802185}} (1968); Chem. Abstr., 70: 96640c (1969).</ref><ref>{{Cite patent|CH|534129}} (1973); Chem. Abstr., 79: 18582g (1973).</ref>]]
Clonixin was reacted with [[chloroacetonitrile]] and [[triethylamine]] to give '''2'''. Heating with [[potassium carbonate]] and [[glycerol actonide]] displaced the [[activating group]] to produce ester '''3''', which was deblocked in [[acetic acid]] to produce clonixeril ('''4''').

==See also==
*[[Flunixin]]
*[[Clonixeril]]

== References ==
{{reflist}}

{{Prostanoidergics}}

[[Category:Nonsteroidal anti-inflammatory drugs]]
[[Category:Chloroarenes]]
[[Category:Pyridines]]
[[Category:Anilines]]
[[Category:Aromatic acids]]


{{musculoskeletal-drug-stub}}